Ernest Moles

655 total citations
19 papers, 439 citations indexed

About

Ernest Moles is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Virology. According to data from OpenAlex, Ernest Moles has authored 19 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Public Health, Environmental and Occupational Health, 10 papers in Molecular Biology and 4 papers in Virology. Recurrent topics in Ernest Moles's work include Malaria Research and Control (8 papers), RNA Interference and Gene Delivery (5 papers) and HIV Research and Treatment (4 papers). Ernest Moles is often cited by papers focused on Malaria Research and Control (8 papers), RNA Interference and Gene Delivery (5 papers) and HIV Research and Treatment (4 papers). Ernest Moles collaborates with scholars based in Spain, Australia and Singapore. Ernest Moles's co-authors include Xavier Fernàndez‐Busquets, Patricia Urbán, Maria Antònia Busquets, Joana Marques, Maria Kavallaris, Julie Movellan, José Luís Serrano, Jesús M. de la Fuente, Íñigo Angulo‐Barturen and Marı́a Belén Jiménez-Dı́az and has published in prestigious journals such as Biomaterials, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Ernest Moles

19 papers receiving 436 citations

Peers

Ernest Moles
Simi Gunaseelan United States
Jasmin Federizon United States
Eirini D. Tseligka Switzerland
Weixi Zhong United States
Tais A. P. F. Doll United States
Ernest Moles
Citations per year, relative to Ernest Moles Ernest Moles (= 1×) peers Martha Kalkanidis

Countries citing papers authored by Ernest Moles

Since Specialization
Citations

This map shows the geographic impact of Ernest Moles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ernest Moles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ernest Moles more than expected).

Fields of papers citing papers by Ernest Moles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ernest Moles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ernest Moles. The network helps show where Ernest Moles may publish in the future.

Co-authorship network of co-authors of Ernest Moles

This figure shows the co-authorship network connecting the top 25 collaborators of Ernest Moles. A scholar is included among the top collaborators of Ernest Moles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ernest Moles. Ernest Moles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Moles, Ernest, et al.. (2025). Harnessing antiviral RNAi therapeutics for pandemic viruses: SARS-CoV-2 and HIV. Drug Delivery and Translational Research. 15(7). 2301–2322. 3 indexed citations
2.
Howard, Christopher B., Pie Huda, Kathleen Kimpton, et al.. (2024). Targeted delivery of polo-like kinase 1 siRNA nanoparticles using an EGFR-PEG bispecific antibody inhibits proliferation of high-risk neuroblastoma.. Journal of Controlled Release. 367. 806–820. 12 indexed citations
3.
Moles, Ernest, David Chang, Friederike M. Mansfeld, et al.. (2024). EGFR Targeting of Liposomal Doxorubicin Improves Recognition and Suppression of Non-Small Cell Lung Cancer. International Journal of Nanomedicine. Volume 19. 3623–3639. 12 indexed citations
4.
Schofield, Peter, Hannah McCalmont, Ernest Moles, et al.. (2023). An antibody fragment-decorated liposomal conjugate targets Philadelphia-like acute lymphoblastic leukemia. International Journal of Biological Macromolecules. 254(Pt 1). 127596–127596. 4 indexed citations
5.
Mariana, Anna, Ernest Moles, Timothy W. Failes, et al.. (2022). Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia. Frontiers in Oncology. 11. 779859–779859. 3 indexed citations
6.
Connerty, Patrick, Ernest Moles, Charles E. de Bock, et al.. (2021). Development of siRNA-Loaded Lipid Nanoparticles Targeting Long Non-Coding RNA LINC01257 as a Novel and Safe Therapeutic Approach for t(8;21) Pediatric Acute Myeloid Leukemia. Pharmaceutics. 13(10). 1681–1681. 44 indexed citations
7.
Lantero, Elena, et al.. (2020). Development of DNA Aptamers Against Plasmodium falciparum Blood Stages Using Cell-Systematic Evolution of Ligands by EXponential Enrichment. Journal of Biomedical Nanotechnology. 16(3). 315–334. 7 indexed citations
8.
Moles, Ernest, Maria Kavallaris, & Xavier Fernàndez‐Busquets. (2019). Modeling the Distribution of Diprotic Basic Drugs in Liposomal Systems: Perspectives on Malaria Nanotherapy. Frontiers in Pharmacology. 10. 1064–1064. 8 indexed citations
9.
Moles, Ernest, et al.. (2019). An ImmunoPEGliposome for Targeted Antimalarial Combination Therapy at the Nanoscale. Pharmaceutics. 11(7). 341–341. 25 indexed citations
10.
Quiliano, Miguel, Adriana Pabón, Ernest Moles, et al.. (2018). Structure-activity relationship of new antimalarial 1-aryl-3-susbtituted propanol derivatives: Synthesis, preliminary toxicity profiling, parasite life cycle stage studies, target exploration, and targeted delivery. European Journal of Medicinal Chemistry. 152. 489–514. 4 indexed citations
11.
Moles, Ernest, Josep Marcos, Santıago Imperial, Óscar J. Pozo, & Xavier Fernàndez‐Busquets. (2017). 2-picolylamine derivatization for high sensitivity detection of abscisic acid in apicomplexan blood-infecting parasites. Talanta. 168. 130–135. 6 indexed citations
12.
Moles, Ernest, Silvia Galiano, Ana Gomes, et al.. (2017). ImmunoPEGliposomes for the targeted delivery of novel lipophilic drugs to red blood cells in a falciparum malaria murine model. Biomaterials. 145. 178–191. 34 indexed citations
13.
Ch’ng, Jun-Hong, Kirsten Moll, Ernest Moles, et al.. (2016). Rosette-Disrupting Effect of an Anti-Plasmodial Compound for the Potential Treatment of Plasmodium falciparum Malaria Complications. Scientific Reports. 6(1). 29317–29317. 16 indexed citations
14.
Moles, Ernest, Kirsten Moll, Jun-Hong Ch’ng, et al.. (2016). Development of drug-loaded immunoliposomes for the selective targeting and elimination of rosetting Plasmodium falciparum- infected red blood cells. Journal of Controlled Release. 241. 57–67. 22 indexed citations
15.
Moles, Ernest, Patricia Urbán, Marı́a Belén Jiménez-Dı́az, et al.. (2015). Immunoliposome-mediated drug delivery to Plasmodium -infected and non-infected red blood cells as a dual therapeutic/prophylactic antimalarial strategy. Journal of Controlled Release. 210. 217–229. 68 indexed citations
16.
Moles, Ernest, Juan José Valle‐Delgado, Patricia Urbán, et al.. (2015). Possible Roles of Amyloids in Malaria Pathophysiology. Future Science OA. 1(2). FSO43–FSO43. 3 indexed citations
17.
Movellan, Julie, Patricia Urbán, Ernest Moles, et al.. (2014). Amphiphilic dendritic derivatives as nanocarriers for the targeted delivery of antimalarial drugs. Biomaterials. 35(27). 7940–7950. 71 indexed citations
18.
Marques, Joana, Ernest Moles, Patricia Urbán, et al.. (2014). Application of heparin as a dual agent with antimalarial and liposome targeting activities toward Plasmodium-infected red blood cells. Nanomedicine Nanotechnology Biology and Medicine. 10(8). 1719–1728. 50 indexed citations
19.
Urbán, Patricia, et al.. (2012). Nanotools for the Delivery of Antimicrobial Peptides. Current Drug Targets. 13(9). 1158–1172. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026